Resources
2 Results (showing 1 - 2)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 2/28/2023 (updated 3/27/2024)
In November 2022, the FDA issued a letter providing information on the severe ulcerations that can occur from repeated xylazine exposure, withdrawal symptoms, and the interference xylazine can cause on successful treatment. The FDA continues to investigate the source of xylazine in the illicit drug supply. Health care professionals are strongly encouraged to report events in humans associated with xylazine exposure.
Posted 6/8/2022 (updated 3/27/2024)
The experience of Jenna Tatro’s substance use disorder and her subsequent overdose death has mobilized Jenna’s family and the Jenna’s Promise team to try and address the gaps in our current national recovery model, culminating in the formation of what aims to be a paradigm-shifting pathway to sustained recovery.